His research focuses on diseases such as acute myeloid leukemia, myelodysplastic syndromes, and immune thrombocytopenia, as well as the development of innovative techniques for monitoring and analysis of minimal residual disease in acute myeloid leukemia and in other hematological malignancies. Dr. Buccisano is president of the Italian Society for Cytometric Cell Analysis, a member of the European LeukemiaNet Working Party for Minimal Residual Disease in leukemia and of the board of the European Society of Clinical Cell Analysis (ESCCA), and secretary of the Acute Leukemia Working Party of the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA). He has over 160 publications in peer-reviewed journals and a personal H-index of 38 (as of April 2022).